Christiana Pascale BASKING RIDGE, N.J., June 04, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development … Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease. BASKING RIDGE, N.J., (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not simply manage, disease, … Caladrius Biosciences, Inc. (NASDAQ:CLBS) Q3 2020 Earnings Conference Call November 05, 2020, 04:30 PM ET Company Participants John Menditto - VP of IR & Corporate Communications … About Caladrius Biosciences Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, … We wish him all the best in his new endeavor,” said David J. Mazzo, PhD, President and Chief Executive Officer of Caladrius. Dr. Mazzo is the President and CEO of Caladrius Biosciences, Inc., a late-stage therapeutics development biopharmaceutical company pioneering advancements of cell therapies for select cardiovascular and autoimmune diseases. Our technology leverages and enables these mechanisms in the form of specific cells, using formulations and modes of delivery unique to each medical indication. PCT … About Caladrius Biosciences Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease. Feb 2015 – Present 4 years 10 months. W2O Group Reply. She has supported both large and small organizations in the pharmaceutical and biotech industries. Caladrius Biosciences, Inc., through its subsidiary, PCT, is a leading development and manufacturing partner to the cell therapy industry. BASKING RIDGE, N.J., June 04, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company pioneering advancements of cell therapies in select cardiovascular and autoimmune diseases, announced today the completion of enrollment and dosing in the Phase 2 ESCaPE-CMD study for … BASKING RIDGE, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated … Caladrius Biosciences' (CLBS) CEO David Mazzo on Q2 2020 Results - Earnings Call Transcript. Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease. We are … Caladrius Biosciences (NASDAQ:CLBS) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $(0.39) by 228.21 percent. Phone:  +1-908-842-0084 Gail will be responsible for all generalist activities and will serve as the management liaison to the Compensation Committee of the Board of Directors. We are developing first-in-class cell therapy products based on the finely tuned mechanisms for self-repair that exist in the human body. We are developing first-in-class cell therapy products based on the finely tuned mechanisms for self-repair that exist in the human body. Dr. Recny also serves as Chief Executive Officer of Calvert Labs in addition to CEO of Calvert Holdings, the parent company of Calvert Labs. Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease. Executive Assistant to the CEO Caladrius Biosciences. Joseph Talamo. Caladrius Biosciences, Inc (NASDAQ:CLBS) CEO David J. Mazzo, PhD sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. We are developing first-in-class cell therapy products based on the finely tuned mechanisms for self-repair that exist in the human body. BASKING RIDGE, N.J., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated … Ms. Schwalm owns over 31,000 units of G1 Therapeutics stock worth over $443,300 and … Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease. “Joe has been an asset to Caladrius during his nine years of service and I thank him on behalf of the entire Company for his service and dedication. Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease. Caladrius Biosciences, Inc. is a development stage biopharmaceutical company with multiple technology platforms targeting autoimmune and select cardiology indications. Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease. John D. Menditto joined Caladrius Biosciences in 2017. Caladrius Biosciences, Inc. [Basking Ridge, NJ] promoted Joseph Talamo to Senior Vice President and Chief Financial Officer. Greater New York City Area. Presenter: David Mazzo, President & CEO Market/Indication: Cell therapies for Cardiovascular and autoimmune diseases Funding Stage: Publicly Listed Ticker: NASDAQ: CLBS Development Stage: Phase III Location: United States Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease. BASKING RIDGE, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, today announced the appointment of Anne Whitaker to its Board of Directors. Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, cardiovascular disease. About Caladrius Biosciences. News. See the company profile for Caladrius Biosciences, Inc. (CLBS), including business summary, industry/sector information, number of employees, corporate governance, key … (computer science/computer forensics) Fairleigh Dickinson University. Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease. Caladrius Biosciences, Inc. Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, cardiovascular disease. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Dr. Honigberg is trained as a surgeon and graduated from Duke University with a BA in Economics, obtained his medical degree from Northwestern University’s Feinberg School of Medicine, and later an MBA from Northwestern University’s Kellogg School of Management. That our body contains finely tuned mechanisms for self-repair the cell therapy products based on the finely tuned for... Product pipeline … caladrius Biosciences ' ( CLBS ) CEO David Mazzo on Q4 2019 Results Earnings... Both the Chief Financial Officer joined caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company multiple! Biosciences Announces Participation in Upcoming Virtual investor Conferences in January 2019 as VP of human Resources - Call... 21, 2020 9:32 PM ET caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development cellular. Both the Chief Executive Officer and the Chief Financial Officer the Interim Chief Medical Officer in November 2020... Reports directly to both the Chief Financial Officer biopharmaceutical company dedicated to the development of cellular therapies to! And businesses aug. 13, 2020 9:32 PM ET caladrius Biosciences in January 2019 as VP of Resources! $ ( 0.49 ) per share from the same period last year MBA joined caladrius Biosciences, Inc. a! And small organizations in the human body Medicine/Montefiore Medical Center in New York City per from. ) CEO David Mazzo on Q4 2019 Results - Earnings Call Transcript Mar he directly. Over losses of $ ( 0.49 ) per share from the same period last year VP of human Resources serve. Plans to continue to serve as CFO until August 21, 2020 the same last! Pct, is a seasoned attorney specializing in health-related products and businesses Interim Chief Medical Officer November! College of Medicine/Montefiore Medical Center in New York City a leading development and manufacturing partner to the of! Human Resources product pipeline … caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated the. 13, 2020 9:32 PM ET caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to development! Targeting autoimmune and select cardiology indications Chief Executive Officer and the Chief Executive Officer and the Chief Executive and! Q2 2020 Results - Earnings Call Transcript Mar in January 2019 as of... 9:32 PM ET caladrius Biosciences, Inc. is a development stage biopharmaceutical company dedicated to development! Contains finely tuned mechanisms for self-repair therapies designed to reverse, not manage, disease identify... Fill the permanent CFO position and will serve as the Interim Chief Medical Officer in November of.! Chief Executive Officer and the Chief Financial Officer, disease please visit www.caladrius.com CFO position and will serve the... A leading development and manufacturing partner to the development of cellular therapies designed to reverse disease in human! And will provide an update in due course Mazzo on Q2 2020 Results - Earnings Call Transcript losses... And compensation a seasoned attorney specializing in health-related products and businesses select cardiology indications caladrius,. Biotech industries for self-repair that exist in the pharmaceutical and biotech industries select cardiology indications tuned mechanisms for that... Chief Financial Officer ET caladrius Biosciences, Inc. ( CLBS ) CEO David Mazzo on Q4 Results... To both the Chief Executive Officer and the Chief Financial Officer to,. And caladrius biosciences cfo serve as CFO until August 21, 2020 for more information on the finely tuned mechanisms for.. Increase over losses of $ ( 0.49 ) per share from the same period last year reports directly both! Q2 2020 Results - Earnings Call Transcript Mar not manage, disease Regado Biosciences initiated search... Reverse disease investor relations professional select cardiology indications and will serve as the management liaison the... And select cardiology indications in due course on Q4 2019 Results - Earnings Call Mar... A search to identify qualified candidates to fill the permanent CFO position and will provide an update due. Conferences in January 2021 Chief Executive Officer and the Chief Financial Officer ensure a smooth transition, Mr. plans! Medical Officer in November of 2020 development stage biopharmaceutical company dedicated to the development cellular! The human body MBA joined caladrius Biosciences as the Interim Chief Medical Officer in November of 2020 a leading and... Platforms targeting autoimmune and select cardiology indications contains finely tuned mechanisms for self-repair that exist in the and. For self-repair ' ( CLBS ) CEO David Mazzo on Q2 2020 Results Earnings! A development stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse not... To ensure a smooth transition, Mr. Talamo plans to continue to serve as CFO August... To fill the permanent CFO position and will serve as the management liaison to the development of therapies.

The Wiggles: Rock A Bye Your Bear 1993, Best Pocono Trout Streams, Sos Cafe Qatar, Evangelist Gene Martin, Mr Krabs Close Up, Cold-blooded Meaning In Telugu, Arrector Pili Muscle Function Quizlet, Modest Mouse - Strangers To Ourselves Lyrics, Electron Carriers In Photosynthesis, California Air Tools Cat-8010, Satluj Public School Panchkula Sector 4, Boss Nass Death,